Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
A number of antihypertensive drugs are known to be diabetogenic. This may contribute to less than expected decrease in the incidence of coronary heart disease with reduction in blood pressure with treatment in hypertensive patients. This study was aimed to determine the effects of a member, Valsarta...
Saved in:
Main Authors: | Ayob, Azizi, Hashim, Suhaimi, Azdan, Zulnizam, Abdul Razak, Tariq |
---|---|
Format: | Article |
Language: | English |
Published: |
Islamic World Academy of Sciences
2006
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/399/1/Medical_Journal_of_Islamic_World_Academy_of_Sciences.pdf http://irep.iium.edu.my/399/ http://www.medicaljournal-ias.org/tr/Icerik.aspx?IcerikID=124 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
by: Ummu Kulthum, Jamaludin
Published: (2013) -
Involvement of AT1 angiotensin receptors in the vasomodulatory effect of des-aspartate-angiotensin I in the rat renal vasculature
by: Dharmani, M., et al.
Published: (2008) -
Kesan in vitro rilmenidine ke atas rembesan insulin
by: Hashim, Rosnani, et al.
Published: (2003) -
Involvement of AT1 angiotensin receptors in the vasomodulatory effect of des-aspartate-angiotensin I in the rat renal vasculature
by: Dharmani, M., et al.
Published: (2008) -
Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo-and hypertensive rats
by: Mustafa, M.R., et al.
Published: (2004)